Aceso Pharmaceuticals entered the industry of Research and Development Laboratories in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact Nidhi Arora by calling No number given during business hours. You can also write to the business’ Single Location at 13127 Kellam Court Apartment 31, San Diego, California CA 92130. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Aceso Pharmaceuticals |
Representative: | Nidhi Arora |
Place of Business: | 13127 Kellam Court Apartment 31, San Diego, CA 92130 |
Contact Number: | No number given |
Type of Service: | Research and Development Laboratories |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2011 |
Income/Year: | $0 to $49.999 |
Laborers: | 1 to 4 |
Share This Company: |
Aceso Pharmaceuticals is a company operating from San Diego, California providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2011 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.
With a current employee count of 1 to 4, Aceso Pharmaceuticals has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Nidhi Arora at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 13127 Kellam Court Apartment 31 in San Diego, California 92130 and can be engaged online through the company website at , the company Twitter , and Facebook page .